$OKLO

Oklo Q2 Revenue Rises To $1.2 Mln From Zero Last Year, Loss Widens; Stock Up In Pre-Market

Oklo Inc. (OKLO) reported Q2 results. Net loss widened to $48.5 million, or $0.28 per share, from $24.7 million, or $0.18 per share, a year earlier. Revenue rose to $1.2 million from zero. Operating expenses increased to $74.4 million from $28.01 million. In pre-market, OKLO traded at $44.05, up 4.27%.

Original reporting
Published Aug 7, 2026, 12:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 12:54 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Oklo Q2 Revenue Rises To $1.2 Mln From Zero Last Year, Loss Widens; Stock Up In Pre-Market — source image
Decision brief

The 30-second read

$OKLONeutralMed
01

Why it matters

Traders can reassess near-term risk premium after the first reported revenue quarter, but without forward guidance or balance-sheet details, conviction may be limited.

02

Market read

A first-quarter revenue print alongside a wider loss can drive short-term repricing, but follow-through depends on cash runway and any stated outlook.

03

What to watch

The article omits cash on hand, guidance, backlog, and project milestones; those items often dominate follow-through after early-stage revenue prints.

Relevance 7/10Novelty 6/10Timing: pre-market today

Background

Oklo is an early-stage company where quarterly revenue can be sporadic, and operating expense trends often signal burn rate and execution risk.

Company-level read

Ticker impact

$OKLONeutralMedium confidence
Context

Oklo reported Q2 revenue of $1.2M versus zero a year ago, while net loss widened to $48.5M, driving a pre-market stock move.

Expected impact

Near-term volatility likely remains elevated as traders weigh first revenue against a larger loss and expense ramp.

Evidence & confidence

The article provides concrete Q2 financial datapoints (revenue, net loss, operating expenses) and notes a same-day pre-market gain, but lacks guidance, cash balance, or forward outlook to confirm a durable trend.

Market effects

For nuclear/advanced energy developers, the print reinforces the trade-off between early revenue recognition and heavy operating expense burn.

No specific regional spillover is described beyond a US pre-market move.

No global policy, supply chain, or international demand drivers are mentioned.

Counterpoint

The revenue base is small ($1.2M) and the loss widened sharply, so the stock pop may fade if investors focus on cash burn rather than revenue emergence.

Key entities

  • Oklo Inc.

    Reported Q2 results: revenue $1.2M, net loss $48.5M, operating expenses $74.4M, and stock up in pre-market.

Related articles

$OKLOMed

Oklo Inc. Q2 2026 Earnings Call Summary

Oklo Inc. reported progress from its Q2 2026 earnings call, including first criticality at the Groves isotope facility and plans for Aurora deployments at INL and an Ohio clean energy campus. The company targeted 2028 commercial startup, expected first isotope revenue in early 2027, and raised 2026 operating cash use guidance to $120M-$150M and PP&E spend to $400M-$500M.

$OKLOMed

Oklo Stock Attempts a Turnaround, but Technical Barriers Remain as It Releases Q2 2026 Financial Results

Oklo reported Q2 2026 revenue of $1.2 million, above analysts’ ~$83,800 estimate, but posted a $0.28 per-share loss versus a ~$0.16 consensus. Net loss widened to $48.5 million from $24.7 million a year earlier. The company ended the quarter with about $3 billion in cash and marketable securities and said its Groves Isotope Test Reactor achieved first criticality.

$OKLOMedAI 8/10

Oklo reports $1.21M Q2 revenue, $1.6B cash as Aurora milestones advance

Oklo Inc. (NYSE: OKLO) reported Q2 2026 revenue of $1.21M versus a $126,250 analyst estimate and an EPS loss of $(0.28) versus an estimated $(0.16). The company said it ended the quarter with $1.6B cash and expects 2026 operating cash flow of $120M to $150M and capex of $400M to $500M. It also advanced Aurora regulatory steps and said its Groves reactor reached first criticality.

$OKLOMed

Oklo's Groves Reactor Just Achieved First Criticality. Here's What It Means for OKLO Stock.

Oklo said its Groves Isotope Test Reactor in Texas achieved first criticality on Aug. 5, marking the first self-sustaining fission chain reaction at the Groves site, according to the company. Oklo noted it was the first DOE Reactor Pilot Program project to reach criticality from a greenfield private-land site. The firm reiterated targets for Aurora-INL late 2027 to early 2028 and Aurora-Ohio startup in early 2030.

$OKLOMedAI 8/10

OKLO Q2 FY2026 earnings call — BigGo Finance

Oklo Inc. reported a first-half 2026 net loss of $81.6 million, with operating loss of $124.2 million offset by $44.5 million of net interest and dividend income, and no revenue recognized. Cash and marketable securities were $3.0 billion at June 30, 2026. Management raised FY2026 operating cash use to $120 million-$150 million and capex to $400 million-$500 million. Key updates include Groves first criticality and DOE progress for Aurora-INL.